131 related articles for article (PubMed ID: 18849487)
1. Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors.
Iwanaga M; Tagawa M; Tsukasaki K; Matsuo T; Yokota K; Miyazaki Y; Fukushima T; Hata T; Imaizumi Y; Imanishi D; Taguchi J; Momita S; Kamihira S; Tomonaga M
Blood; 2009 Feb; 113(8):1639-50. PubMed ID: 18849487
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
Iwanaga M; Tomonaga M
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan.
Iwanaga M; Tagawa M; Tsukasaki K; Kamihira S; Tomonaga M
Mayo Clin Proc; 2007 Dec; 82(12):1474-9. PubMed ID: 18053454
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal gammopathy in atomic bomb survivors.
Neriishi K; Yoshimoto Y; Carter RL; Matsuo T; Ichimaru M; Mikami M; Abe T; Fujimura K; Kuramoto A
Radiat Res; 1993 Mar; 133(3):351-9. PubMed ID: 8451386
[TBL] [Abstract][Full Text] [Related]
5. Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima.
Fujimura K; Sugiyama A; Akita T; Ohisa M; Nagashima S; Katayama K; Maeda R; Tanaka J
Int J Hematol; 2021 Apr; 113(4):576-585. PubMed ID: 33389658
[TBL] [Abstract][Full Text] [Related]
6. [Monoclonal gammopathy of uncertain significance (MGUS) and ionizing radiation].
Taino G; Buonocore C; Stanga A; Imbriani M
G Ital Med Lav Ergon; 2020 Dec; 42(4):292-297. PubMed ID: 33600657
[TBL] [Abstract][Full Text] [Related]
7. Association of radiation dose with prevalence of thyroid nodules among atomic bomb survivors exposed in childhood (2007-2011).
Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
JAMA Intern Med; 2015 Feb; 175(2):228-36. PubMed ID: 25545696
[TBL] [Abstract][Full Text] [Related]
8. Exposure to Atomic Bomb Radiation and Age-Related Macular Degeneration in Later Life: The Hiroshima-Nagasaki Atomic Bomb Survivor Study.
Itakura K; Takahashi I; Nakashima E; Yanagi M; Kawasaki R; Neriishi K; Wang JJ; Wong TY; Hida A; Ohishi W; Kiuchi Y
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5401-6. PubMed ID: 26275137
[TBL] [Abstract][Full Text] [Related]
9. Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.
Grant EJ; Furukawa K; Sakata R; Sugiyama H; Sadakane A; Takahashi I; Utada M; Shimizu Y; Ozasa K
Lancet Oncol; 2015 Oct; 16(13):1316-23. PubMed ID: 26384241
[TBL] [Abstract][Full Text] [Related]
10. High Excess Risk of Heart Disease Mortality among Hiroshima Atomic Bomb Male Survivors Exposed Near the Hypocenter.
Hara N; Satoh K; Otani K; Kawakami H; Ohtaki M
Hiroshima J Med Sci; 2016 Sep; 65(2):45-51. PubMed ID: 29989684
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal gammopathy of undetermined significance in atomic bomb survivors: incidence and transformation to multiple myeloma.
Neriishi K; Nakashima E; Suzuki G
Br J Haematol; 2003 May; 121(3):405-10. PubMed ID: 12716362
[TBL] [Abstract][Full Text] [Related]
12. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
[TBL] [Abstract][Full Text] [Related]
13. High Initial-dose Dependency of Cerebrovascular Disease Mortality among Female Survivors of the Hiroshima Atomic Bomb Exposed in Teens: A Cohort Study, 1970-2010.
Matsuba J; Otani K; Satoh K; Kawakami H; Ohtaki M
Hiroshima J Med Sci; 2016 Sep; 65(2):35-43. PubMed ID: 29989683
[TBL] [Abstract][Full Text] [Related]
14. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003.
Shimizu Y; Kodama K; Nishi N; Kasagi F; Suyama A; Soda M; Grant EJ; Sugiyama H; Sakata R; Moriwaki H; Hayashi M; Konda M; Shore RE
BMJ; 2010 Jan; 340():b5349. PubMed ID: 20075151
[TBL] [Abstract][Full Text] [Related]
15. Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors.
Iwanaga M; Hsu WL; Soda M; Takasaki Y; Tawara M; Joh T; Amenomori T; Yamamura M; Yoshida Y; Koba T; Miyazaki Y; Matsuo T; Preston DL; Suyama A; Kodama K; Tomonaga M
J Clin Oncol; 2011 Feb; 29(4):428-34. PubMed ID: 21149671
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal gammopathy of uncertain significance (MGUS) and occupational risk factors: criteria to carry out the health surveillance].
Taino G; Bordini L; Sarto C; Porro S; Chirico F; Oddone E; Imbriani M
G Ital Med Lav Ergon; 2019 Jul; 41(3):202-207. PubMed ID: 31242349
[TBL] [Abstract][Full Text] [Related]
17. Japanese Legacy Cohorts: The Life Span Study Atomic Bomb Survivor Cohort and Survivors' Offspring.
Ozasa K; Grant EJ; Kodama K
J Epidemiol; 2018 Apr; 28(4):162-169. PubMed ID: 29553058
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological studies of atomic bomb radiation at the Radiation Effects Research Foundation.
Ozasa K; Cullings HM; Ohishi W; Hida A; Grant EJ
Int J Radiat Biol; 2019 Jul; 95(7):879-891. PubMed ID: 30676179
[TBL] [Abstract][Full Text] [Related]
19. Cataract in atomic bomb survivors.
Minamoto A; Taniguchi H; Yoshitani N; Mukai S; Yokoyama T; Kumagami T; Tsuda Y; Mishima HK; Amemiya T; Nakashima E; Neriishi K; Hida A; Fujiwara S; Suzuki G; Akahoshi M
Int J Radiat Biol; 2004 May; 80(5):339-45. PubMed ID: 15223766
[TBL] [Abstract][Full Text] [Related]
20. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children.
Preston DL; Cullings H; Suyama A; Funamoto S; Nishi N; Soda M; Mabuchi K; Kodama K; Kasagi F; Shore RE
J Natl Cancer Inst; 2008 Mar; 100(6):428-36. PubMed ID: 18334707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
